Publikace
- Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial2003 | 1. lékařská fakulta
- Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: Why are the markers poorly accepted by clinicians?2003 | 1. lékařská fakulta
- Kvalita kosti: které účinky léčby můžeme monitorovat a co to předpokládá?2003 | 1. lékařská fakulta
- Růstový hormon a kostní tkáň2006 | 1. lékařská fakulta
- Osteoporóza u mužů2006 | 1. lékařská fakulta
- No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in caucasian females2006 | 1. lékařská fakulta
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | 1. lékařská fakulta
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study2006 | 1. lékařská fakulta
- Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study2006 | 1. lékařská fakulta
- Clinical value of the biochemical markers of bone remodeling in the assessment of bone metabolic diseases2006 | 1. lékařská fakulta
Loading network view...